These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 15502474)

  • 1. The economic burden of dry eye: a conceptual framework and preliminary assessment.
    Reddy P; Grad O; Rajagopalan K
    Cornea; 2004 Nov; 23(8):751-61. PubMed ID: 15502474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost of dry eye treatment in an Asian clinic setting.
    Waduthantri S; Yong SS; Tan CH; Shen L; Lee MX; Nagarajan S; Hla MH; Tong L
    PLoS One; 2012; 7(6):e37711. PubMed ID: 22701577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The annual cost of dry eye syndrome in France, Germany, Italy, Spain, Sweden and the United Kingdom among patients managed by ophthalmologists.
    Clegg JP; Guest JF; Lehman A; Smith AF
    Ophthalmic Epidemiol; 2006 Aug; 13(4):263-74. PubMed ID: 16877285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relative costs of various preserved artificial tear solutions for the treatment of dry eye conditions.
    Enzenauer RW; Kao A; Williams T; Lambert RW
    Eye Contact Lens; 2003 Oct; 29(4):238-40. PubMed ID: 14555900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The economic burden of dry eye disease in the United States: a decision tree analysis.
    Yu J; Asche CV; Fairchild CJ
    Cornea; 2011 Apr; 30(4):379-87. PubMed ID: 21045640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. United States cost-effectiveness study of two dry eye ophthalmic lubricants.
    Wlodarczyk J; Fairchild C
    Ophthalmic Epidemiol; 2009; 16(1):22-30. PubMed ID: 19191178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence, burden, and pharmacoeconomics of dry eye disease.
    Pflugfelder SC
    Am J Manag Care; 2008 Apr; 14(3 Suppl):S102-6. PubMed ID: 18452369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Considerations in the pharmacoeconomics of dry eye.
    Hirsch JD
    Manag Care; 2003 Dec; 12(12 Suppl):33-8. PubMed ID: 14723112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacoeconomics of anterior ocular inflammatory disease.
    Bielory L; Syed BA
    Curr Opin Allergy Clin Immunol; 2013 Oct; 13(5):537-42. PubMed ID: 23945174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequency of dry eye diagnostic test procedures used in various modes of ophthalmic practice.
    Nichols KK; Nichols JJ; Zadnik K
    Cornea; 2000 Jul; 19(4):477-82. PubMed ID: 10928762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Economic and Humanistic Burden of Dry Eye Disease in Europe, North America, and Asia: A Systematic Literature Review.
    McDonald M; Patel DA; Keith MS; Snedecor SJ
    Ocul Surf; 2016 Apr; 14(2):144-67. PubMed ID: 26733111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What We Know About the Epidemiology of Dry Eye Disease in Japan.
    Uchino M
    Invest Ophthalmol Vis Sci; 2018 Nov; 59(14):DES1-DES6. PubMed ID: 30481799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new look at dry eye disease and its treatment.
    Nelson JD; Helms H; Fiscella R; Southwell Y; Hirsch JD
    Adv Ther; 2000; 17(2):84-93. PubMed ID: 11010059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dry eye in the elderly.
    Terry MA
    Drugs Aging; 2001; 18(2):101-7. PubMed ID: 11346124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Staged therapy for the dry eye.
    Farris RL
    CLAO J; 1991 Jul; 17(3):207-15. PubMed ID: 1893546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of Dry Eye Symptoms: Current Trends and Issues of Dry Eye Questionnaires in Japan.
    Shiraishi A; Sakane Y
    Invest Ophthalmol Vis Sci; 2018 Nov; 59(14):DES23-DES28. PubMed ID: 30481802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Economic impact of migraine and other episodic headaches in France: data from the GRIM2000 study.
    Pradalier A; Auray JP; El Hasnaoui A; Alzahouri K; Dartigues JF; Duru G; Henry P; Lantéri-Minet M; Lucas C; Chazot G; Gaudin AF
    Pharmacoeconomics; 2004; 22(15):985-99. PubMed ID: 15449963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Online Information on Complementary and Alternative Treatments for Dry Eye Disease.
    Rapata MEJ; Meyer JJ
    Optom Vis Sci; 2021 Apr; 98(4):355-361. PubMed ID: 33852552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Dry eye].
    Roncin S
    Rev Prat; 2001 Jan; 51(2):140-7. PubMed ID: 11252938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attitudes towards diagnostic tests and therapies for dry eye disease.
    Graham JE; McGilligan VE; Berrar D; Leccisotti A; Moore JE; Bron AJ; Moore TC
    Ophthalmic Res; 2010; 43(1):11-7. PubMed ID: 19829007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.